Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (197)

191

Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin

enthalten in: Diabetes, obesity & metabolism | 2012

von Ljunggren, �. | Bolinder, J. | Johansson, L. | +5

192

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride : a randomized, 24-week, double-blind, placebo-controlled trial

enthalten in: Diabetes, obesity & metabolism | 2011

von Strojek, K. | Yoon, K. | Hruba, V. | +3

193

Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

enthalten in: Diabetes, obesity & metabolism | 2011

von Pfützner, A. | Paz-Pacheco, E. | Allen, E. | +3

194

Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment

enthalten in: Diabetes, obesity & metabolism | 2011

von Nowicki, M. | Rychlik, I. | Haller, H. | +104

195

Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes

enthalten in: Diabetes, obesity & metabolism | 2011

von Garber, A. | Henry, R. | Ratner, R. | +104

196

Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes : a randomized controlled trial

enthalten in: Diabetes, obesity & metabolism | 2011

von Del Prato, S. | Barnett, A. | Huisman, H. | +3

CommentIn: Expert Opin Pharmacother. 2011 Dec;12(17):2759-62. - PMID 21883034

197

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes : a randomized, double-blind, placebo-controlled study

enthalten in: Diabetes, obesity & metabolism | 2011

von Taskinen, M. | Rosenstock, J. | Tamminen, I. | +4

CommentIn: Postgrad Med. 2011 Jul;123(4):183-6. - PMID 21681003

[1]
« Vorheriger
10
11
12
13
14
15
16
17
18
19
20